Results

Total Results: 2,204 records

Showing results for "drugs".

341. | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/d
     Diverticulosis and Diverticulitis Domestic Violence Down Syndrome Drug Abuse Drug Reactions Drugs

342. Juvenile Idiopathic Arthritis (JIA) | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/juvenile-idiopathic-arthritis-jia
     November 01, 2017 - Disposition (PDF, 110.5 KB) Project Timeline Disease-Modifying Antirheumatic Drugs

343. Disposition of Comments for CER 178 Newer Medications for Lower Urinary Tract Symptoms (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/prostatic-hyperplasia-medications_disposition-comments.pdf
     May 26, 2016 - Included trials did not report the impact of the combination of these drugs on blood pressure and we … We revised the sentence to clarify: “Recently, newer drugs and drug in other classes approved for … All drugs are FDA-approved and therefore likely to have trials published in English. … We included drugs ‘newly used’ to treat LUTS attributable to BPH. … Drugs with insufficient evidence were added to the anticholinergics paragraph.

344. Hepatitis | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/hepatitis
     April 02, 2014 - If it does not, it can be treated with drugs. Sometimes hepatitis lasts a lifetime.

345. Organ Transplantation | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/organ-transplantation
     March 15, 2016 - If you have a transplant, you must take drugs the rest of your life to help keep your body from rejecting

346. Restless-Legs Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
     November 01, 2012 - Pharmacologic interventions included drugs approved for use (for any condition) in the United States … Pharmacologic interventions were limited to drugs approved for use (for any condition) in the United … We assessed statistical heterogeneity between trials and for subgroups of drugs using the I2 test and … The drugs did not differ with regard to any study withdrawals. … Augmentation, a drug-induced exacerbation of the disease, can occur with dopaminergic drugs.

347. DEcIDE 33: Summary Variables in Observational Resesarch: Propensity Scores and Disease Risk Scores (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/observational-research-scores_research.pdf
     May 01, 2012 - All dispensings of the two drugs were identified, and subjects who received glimepiride who did not … In this example, we assume that there are nine individual drugs of interest, six traditional NSAIDs … Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. … COX-2 selective non-steroidal anti- inflammatory drugs and risk of serious coronary heart disease. … Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs.

348. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive.pdf
     October 01, 2006 - comparing angioplasty with stent placement and “aggressive” medical treatment with currently available drugs … after revascularization do occur in a small percentage of patients, and each of the antihypertensive drugs … blood pressure generally decreased by 20-50/8-42 mm Hg with combinations of multiple antihypertensive drugs … eligibility criteria reported analyses of whether other periprocedural interventions, such as different drugs … eligibility criteria reported analyses of whether other periprocedural interventions, such as different drugs

349. Medical Care Journal Supplement (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/toc.pdf
     January 01, 2007 - Assessment of Adherence to and Persistence on Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Patients … Comparison of Meta-Analytic Results of Indirect, Direct, and Combined Comparisons of Drugs for Chronic

350. Progression-Free Survival: What Does It Mean for Psychological Well-Being or Quality of Life? | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/survival-quality/research
     November 01, 2017 - from any cause, has recently become an endpoint of considerable interest in the study of new oncology drugs … The literature search for KQ2 included terms for drugs approved by one or more regulatory agencies on

351. What evidence exists for programs to increase patient adherence to prescription medications? Which programs/approaches are most effective at increasing adherence for which populations and conditions? If little or no evidence exists, can… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/what-evidence-exists-for-programs-to-increase-patient-adherence-to-prescription-medications-which-programsapproaches-are-most-effective-at-increasing-adherence-for-which-populations-and-conditions-if-little-or-no-evidence-ex
     November 01, 2017 - no If yes, explain the specific technologies, devices, drugs, or interventions you would like to … “Drugs don’t work in patients who don’t take them.” C. Everett Koop, M.D.

352. Disposition of Comments Report for CER 132 Combination Therapy Versus Intensification of Statin Monotherapy: An Update (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
     September 01, 2014 - In fact, after reading the Introduction and all of the difficulties in evaluating these alternate drugs … In some ways there is more harm in adding these drugs as compared to raising the dose of the statins … The relative efficacy and dose ranges for individual statin drugs is shown in Table 4 of the report … Finally, as the report notes there is little to no evidence that adding these alternative drugs to … Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs.

353. Diabetes Mellitus (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
     January 01, 2016 - San Diego (CA): Amylin Pharmaceuticals, Inc.; 2010 Jun 15 [accessed 2011 Feb 22]. [3 p]. … Amylin Pharmaceuticals. … San Diego (CA): Amylin Pharmaceuticals, Inc.; 2012 Jan 27 [accessed 2012 Feb 20]. [4 p]. … San Diego (CA): Amylin Pharmaceuticals, Inc.; 2012 Jan 27. 11 p. … Get drugs straight to the eye. [internet].

354. Long-Term Drug Therapy and Drug Holidays for Osteoporotic Fracture Prevention | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/osteoporosis-fracture-prevention/research-protocol
     May 01, 2019 - Drugs Used for Osteoporosis Treatment and Prevention Drug class Drug Name Delivery Route Dosing Rrequency … Interventions Drugs FDA approved for osteoporosis treatment or prevention (bisphosphonates, denosumab

355. Opioid Abuse and Addiction | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/opioid-abuse-and-addiction
     April 01, 2021 - Addiction is a chronic brain disease that causes a person to compulsively seek out drugs, even though

356. ADHD Medications and Risk of Serious Coronary Heart Disease in Yough and Middle-Aged Adults (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-children_research.pdf
     January 01, 2023 - The study drugs included all medications with a label indication for treatment of ADHD as of December … Study Medications ADHD medications and other drugs of interest were identified from pharmacy records … person-day of follow-up for cohort members was classified according to probable use of study ADHD drugs … ADHD drugs and cardiovascular risk. N Engl J Med 2006 Apr 6;354(14):1445-8. 6. … Atypical antipsychotic drugs and the risk of sudden cardiac death.

357. PROPOSALS FOR A PHASED EVALUATION OF (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/medical-tests-proposals_research.pdf
     January 01, 2009 - Background—In drug development, a four-phase hierarchical model for the clinical evaluation of new pharmaceuticals … Analogous to the four-phase model for the evaluation of new drugs, these models require that certain … Why have the phases in the clinical evaluation of drugs become so well engrained in our thinking, and … The four phases in the development of drugs and devices have shown their merit. … Trials in humans take place only after drugs have been tested thoroughly in the laboratory in animal

358. PROPOSALS FOR A PHASED EVALUATION OF (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/whitepaper3-lijmer02262010-2.pdf
     January 01, 2009 - Background—In drug development, a four-phase hierarchical model for the clinical evaluation of new pharmaceuticals … Analogous to the four-phase model for the evaluation of new drugs, these models require that certain … Why have the phases in the clinical evaluation of drugs become so well engrained in our thinking, and … The four phases in the development of drugs and devices have shown their merit. … Trials in humans take place only after drugs have been tested thoroughly in the laboratory in animal

359. Fatty Liver Disease | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/fatty-liver-disease
     fats in the blood, such as cholesterol and triglycerides Have high blood pressure Take certain drugs … , such as corticosteroids and some cancer drugs Have certain metabolic disorders , including metabolic

360. Proposals for a Phased Evaluation of Medical Tests | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/medical-tests-proposals/research
     December 01, 1969 - Background —In drug development, a four-phase hierarchical model for the clinical evaluation of new pharmaceuticals … Analogous to the four-phase model for the evaluation of new drugs, these models require that certain … Why have the phases in the clinical evaluation of drugs become so well engrained in our thinking, and … The four phases in the development of drugs and devices have shown their merit. … Trials in humans take place only after drugs have been tested thoroughly in the laboratory in animal